title: Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis.
abstract: We have previously shown, using a Cre-LoxP strategy, that vascular endothelial growth factor (VEGF) is required for the development and maintenance of skeletal muscle capillarity in sedentary adult mice. To determine whether VEGF expression is required for skeletal muscle capillary adaptation to exercise training, gastrocnemius muscle capillarity was measured in myocyte-specific VEGF gene-deleted (mVEGF(-/-)) and wild-type (WT) littermate mice following 6 wk of treadmill running (1 h/day, 5 days/wk) at the same running speed. The effect of training on metabolic enzyme activity levels and whole body running performance was also evaluated in mVEGF(-/-) and WT mice. Posttraining capillary density was significantly increased by 59% (P < 0.05) in the deep muscle region of the gastrocnemius in WT mice but did not change in mVEGF(-/-) mice. Maximal running speed and time to exhaustion during submaximal running increased by 20 and 13% (P < 0.05), respectively, in WT mice after training but were unchanged in mVEGF(-/-) mice. Training led to increases in skeletal muscle citrate synthase (CS) and phosphofructokinase (PFK) activities in both WT and mVEGF(-/-) mice (P < 0.05), whereas β-hydroxyacyl-CoA dehydrogenase (β-HAD) activity was increased only in WT mice. These data demonstrate that skeletal muscle capillary adaptation to physical training does not occur in the absence of myocyte-expressed VEGF. However, skeletal muscle metabolic adaptation to exercise training takes place independent of myocyte VEGF expression.
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla, USA. molfert@hsc.wvu.edu
authors.forename: I Mark
authors.initials: IM
authors.lastname: Olfert
authors.forename: Richard A
authors.initials: RA
authors.lastname: Howlett
authors.forename: Peter D
authors.initials: PD
authors.lastname: Wagner
authors.forename: Ellen C
authors.initials: EC
authors.lastname: Breen
mesh_terms: D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000378:metabolism; D000222:Adaptation, Physiological / Q000502:physiology; D000818:Animals; D001835:Body Weight / Q000502:physiology; D002196:Capillaries / Q000502:physiology; D002950:Citrate (si)-Synthase / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D006019:Glycolysis / Q000235:genetics / Q000502:physiology; D007150:Immunohistochemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008822:Mice, Transgenic; D018485:Muscle Fibers, Skeletal / Q000201:enzymology / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000201:enzymology; D018919:Neovascularization, Physiologic / Q000235:genetics* / Q000502:physiology*; D009929:Organ Size / Q000502:physiology; D010101:Oxygen Consumption / Q000235:genetics / Q000502:physiology; D010732:Phosphofructokinase-1 / Q000378:metabolism; D010805:Physical Conditioning, Animal / Q000502:physiology*; D012039:Regional Blood Flow / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics* / Q000502:physiology*
chemical_list: D042461:Vascular Endothelial Growth Factor A; D015094:3-Hydroxyacyl CoA Dehydrogenases; D002950:Citrate (si)-Synthase; D010732:Phosphofructokinase-1